Donate Today!

FOR IMMEDIATE RELEASE
December 5, 2012
4:06 PM

CONTACT: Government Accountability Project

Amanda Hitt, Food Integrity Campaign Director
Phone: 202.457.0034 ext. 159
Email: amandah@whistleblower.org

Jeffery S. Gulley*, Food & Public Health Counsel
Phone: 202.457.0034 ext. 127
Email: jeffg@whistleblower.org
*Licensed only in the Commonwealth of Virginia; Supervised by Richard E. Condit, a D.C. Bar Member.

Dylan Blaylock, Communications Director
Phone: 202.457.0034, ext. 137; 202.236.3733 (cell)
Email: dylanb@whistleblower.org

GAP Sues FDA for Wrongful Withholding of Animal Drug Data

WASHINGTON - December 5 - The Food and Drug Administration's (FDA) decision to withhold agency data regarding the sale of antibiotics for use in food animals is unlawful, the Government Accountability Project (GAP) said in a lawsuit filed today.

Drug companies are required to report basic information about antibiotic sales to the FDA under the Animal Drug User Fee Act (ADUFA). Such information includes how much of each drug is sold; whether the drugs are formulated for use in feed, water, or by injection; and the animals for which each drug is approved. FDA publicly releases a limited summary of ADUFA data each year, but withholds almost all of what companies report.

This lawsuit comes after FDA's failure to respond properly to GAP's Freedom of Information Act (FOIA) request to the agency, which sought data concerning the amount of antibiotics sold for use in food animals in 2009, classified by animal type and dosage information.

The Johns Hopkins Center for a Livable Future (CLF), an academic research center based at the Johns Hopkins Bloomberg School of Public Health, approached GAP for help obtaining these data almost two years ago. GAP made the request in February 2011, and has exhausted all other steps to get the information, short of litigation. In the end, the agency denied GAP’s request, claiming that the requested data is “confidential commercial information.”

“The FDA frequently claims that documents sought through the FOIA process contain ‘confidential commercial information,’” said Jeff Gulley*, GAP Food & Public Health Counsel. “When tested in court, however, these claims frequently don’t hold up. This response by FDA is a violation of FOIA and a wrongful withholding of agency records."

Every year, nearly 30 million pounds of antibiotics – 80 percent of the total antibiotics sold in the United States – are sold for use in food animals. The misuse of antibiotics in industrial animal agriculture drives the development of antibiotic-resistant bacteria that have made human illnesses more dangerous and difficult to treat. Instead of enforcing stricter regulations or providing vital information to the public on this issue, FDA has asked companies to reduce certain uses of antibiotics voluntarily, allowing rampant misuse to continue.

“How can we truly know the extent to which these drugs are causing harm if we can’t even access information?” asked GAP Food Integrity Campaign Director Amanda Hitt. “The agency’s job is to protect the public’s health, not industry secrets.”

“These data will help public health researchers decipher how the industry’s antibiotic use erodes the effectiveness of these life-saving drugs,” said Keeve Nachman, Ph.D., director of the Farming for the Future program at CLF, which has served as a scientific adviser to GAP on the request and lawsuit.

FDA has 30 days to respond to the lawsuit, which can be read in full here.

###
The Government Accountability Project (GAP) is a 30-year-old nonprofit public interest group that promotes government and corporate accountability by advancing occupational free speech, defending whistleblowers, and empowering citizen activists. We pursue this mission through our Nuclear Safety, International Reform, Corporate Accountability, Food & Drug Safety, and Federal Employee/National Security programs. GAP is the nation's leading whistleblower protection organization.


Comments

Note: Disqus 2012 is best viewed on an up to date browser. Click here for information. Instructions for how to sign up to comment can be viewed here. Our Comment Policy can be viewed here. Please follow the guidelines. Note to Readers: Spam Filter May Capture Legitimate Comments...